Clinical Research Center of Indiana

Indianapolis, Indiana 46208

0 studies enrolling now · 6 studies all time

What they study most

Allergic Rhinitis, Asthma, Perennial Allergic Rhinitis, Persistent Allergic Asthma

Studies at this site

• A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) — Completed
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma — Completed
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma — Completed
• Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma — Completed